GlassScriptPhysician profile
Scott M Sanders
NPI 1306815626
$1,254.85
in general payments reported to CMS, 2019-2025
17 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $27.38 · 2021: $80.24 · 2022: $338 · 2023: $378 · 2024: $171 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $488.15 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $161.39 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $117.36 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Supernus Pharmaceuticals, INC. | $93.26 | 2022-2024 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $53.60 | 2019-2025 | |
| Shire North American Group INC | $46.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $40.12 | 2025 | |
| Pfizer INC. | $39.19 | 2023 | |
| Seqirus USA INC | $34.11 | 2022-2023 | Flucelvax Quadrivalent |
| Abbott Laboratories | $30.99 | 2019 | |
| Adlon Therapeutics L.P. | $26.41 | 2020-2021 | |
| Tris Pharma INC | $25.83 | 2021 | |
| Mindray Ds USA, INC. | $23.63 | 2023 | Na Electrode,Indirect,International, Patient Monitor |
| Alexion Pharmaceuticals, INC. | $21.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.43 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $17.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.